NYBC Ventures
Overview
NYBC Ventures is an early-stage life sciences investment fund dedicated to advancing innovations in blood and cellular therapies. The fund invests in therapeutics, devices, and cutting-edge technologi…
Investment Focus
- Companies developing therapeutics, devices, and technologies in blood-related fields and cellular therapies.
Portfolio Companies
Get the full list of 54,000+ investors
NYBC Ventures and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about NYBC Ventures
What sectors does NYBC Ventures invest in?
NYBC Ventures invests in Healthcare, Pharmaceuticals, Medical Devices, Biotechnology, Infectious Diseases and Cell Therapy, and is based in United States. NYBC Ventures is listed as a venture capital in the ConnectSafely investor database.
What stage does NYBC Ventures invest at?
NYBC Ventures backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage.
Which regions does NYBC Ventures invest in?
NYBC Ventures invests across United States.
Who are the partners at NYBC Ventures?
Team members listed for NYBC Ventures include Christopher Hillyer (General Partner) and Jay Mohr (General Partner).
What companies has NYBC Ventures invested in?
NYBC Ventures's portfolio includes Catena Biosciences.
How do I contact NYBC Ventures?
NYBC Ventures's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database